A 52 year old woman presented to her general practitioner with a three month history of excessive and distressing chest and facial sweating. This occurred both day and night (often requiring changes of the bed clothes), and at times was associated with facial flushing. She was otherwise well, her weight was stable, and there was no important medical his tory. Her menstrual cycle had been regular until three years previously but since then had become more erratic, and she had not had a period for 12 months.
What is the next investigation?
Hyperhidrosis (excessive sweating) affects 2.8% of the popula tion. 1 Secondary hyperhidrosis tends to present in adulthood and occurs both during waking and sleeping, unlike primary (idiopathic, essential) hyperhidrosis. Although hyperhidro sis can be due to menopause or drugs, it can also result from underlying medical conditions. The differential diagnosis is similar to that of night sweats and includes infectious or febrile illnesses, neoplastic and neurological disease, endocrine or metabolic disorders, and drugs (box). A full medical history should be taken to ensure no underlying cause is missed, and examination should include assessment of thyroid status and evidence of lymphadenopathy, hepatomegaly, or spleno megaly. A therapeutic trial of withdrawing or reducing any possible contributing drugs should also be considered.
Hyperhidrosis, hot flushes, and night sweats are com monly associated with the menopause, which occurs at a median age of 51 years. 2 Sweating and flushing occur in up to 51% of women before menopausal transition, 3550% during perimenopause, and 3080% after the menopause. 3 Episodes typically start with an unpleasant sensation or sudden onset of a sensation of heat in the face and upper chest, which quickly becomes generalised. It lasts for a few minutes and is associated with profuse perspiration and sometimes palpitations. These flushes are thought to be due to thermoregulatory dysfunction, initiated at the level of the hypothalamus by oestrogen withdrawal. 4 Although sweating in a woman of menopausal age is common, clinicians should not immediately conclude that it is only due to menopausal hot flushes. Measuring gona dotrophins (luteinising hormone and follicle stimulating hormone) and oestradiol can be helpful. Raised luteinis Excessive sweating can be due to menopause or drugs but can also result from neoplastic and neurological disease and endocrine or metabolic disorders 
Outcome
In this patient, gonadotrophin concentrations were high (follicle stimulating hormone 56 IU/l, luteinising hormone 44 IU/l, with oestradiol 46 pmol/l), compatible with a post menopausal state. Because of the severity of her night sweats, it was important to exclude sinister causes. No other features in the history suggested other disease. Examination was entirely normal, as were results of a full blood count and thyroid function tests. It is important to remember that patients can present with menopausal symptoms some time after they have completed the menopause.
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grade fever and drenching night sweats. 5 A full blood count can be normal in Hodgkin's disease, so if lymphadenopathy is present the patient should be referred for appropriate inves tigation. Anaemia may also suggest underlying malignancy. If there is any suspicion of malignancy or tuberculosis a chest radiograph should be done to look for a neoplastic lesion, cavitation, or upper lobe shadowing.
Other endocrinological causes of sweating are rare but it is important they are not missed, and clinical suspicion should lead to referral to a specialist centre. Investigations may include determining serum insulinlike growth factorI concentration if features in keeping with acromegaly are present. Carcinoid syndrome must be excluded in a patient with episodic flushing, usually by measuring 24 hour urinary excretion of 5hydroxyindoleacetic acid (5HIAA), which is the end product of serotonin metabolism. This test has a sensi tivity of 75% and specificity of up to 100%. 6 Although rare, phaeochromocytomas and paragangliomas should be con sidered in a patient with sustained or paroxysmal hyperten sion alongside sweating. Plasma fractionated metanephrines are the first line test, with a sensitivity of up to 100%, but because specificity is 8589% some groups advocate 24 hour urinary metanephrines, which have a sensitivity and specifi city of 98%. 7 8 Investigations for these conditions should be performed in local specialist centres.
Any pointers in the history or examination to suggest underlying infective endocarditis should prompt evaluation
LEARNING POINTS
Hyperhidrosis can result from underlying medical conditions, menopause, or drugs Clinicians should not immediately conclude that sweating in a woman of menopausal age is due to menopausal hot flushes Patients can present with menopausal symptoms some time after they have completed the menopause Initial investigations should include gonadotrophin and oestradiol concentrations to confirm menopausal status, thyroid function tests looking for evidence of hyperthyroidism, and full blood count to help exclude an underlying haematological disorder
LESSON OF THE WEEK
Proton pump inhibitors and acute interstitial nephritis In southeast England during 2007 and 2008, we examined 210 kidney biopsies and found six cases of acute interstitial nephritis that were strongly associated with PPIs either by temporal association with the injury or response to stopping the drugs. These patients had biopsies because renal function was declining, the cause was uncertain, and screening for acute kidney injury was negative. The table summarises five of the six cases of acute interstitial nephritis associated with PPIs (one patient did not consent to be included), and we present two of the cases. Physical examination, including blood pressure, was normal. Urinalysis confirmed a trace of blood and protein.
Screening for acute kidney injury (antinuclear antibodies, antineutrophil cytoplasmic antibodies, complement factors, C3 and C4, and serum and urine electrophoresis) was negative. Proteinuria (urinary protein:creatinine ratio) was 15 mg/mmol (normal range 314 mg/mmol). Kidney function was assessed by plasma creatinine (µmol/l) and estimated glomerular filtration rate (table; patient 1). An ultrasound scan showed normal sized, nonobstructed kidneys.
Kidney biopsy confirmed normal glomeruli and patchy tubulointerstitial lymphocytic infiltrates. An allergictype drug reaction was diagnosed. In view of the temporal asso ciation of omeprazole ingestion and acute kidney injury, the omeprazole was stopped. Lisinopril and domperidone were continued. She was treated with oral prednisolone at 30 mg daily for four weeks and tapered to cessation at three months. Kidney function improved but it did not return to prePPI levels. Renal biopsy confirmed normal glomeruli and focal lym phocytic tubulitis consistent with an acute tubulointersti tial nephritis. Omeprazole was discontinued on 19 March 2008 and prednisolone was started at 30 mg daily, tapered for four months, and then discontinued. Kidney function improved but did not return to normal.
Case 2

Discussion
About 15% of patients admitted to hospital with acute kid ney injury will eventually be diagnosed with acute inter stitial nephritis. 7 Most cases are due to an idiosyncratic reaction to certain drugs, including penicillins and NSAIDs. Since the first case report of acute interstitial nephritis provoked by proton pump inhibitors was published in 1992, 8 all drugs in the PPI class have been associated with reports of acute kidney injury. 5 6 811 The mechanism of renal injury is not fully understood but is thought to involve an immune component. In vitro lymphocyte stimulation tests show response to selected drugs and rapid return of dis ease on inadvertent rechallenge. 12 The standard treatment involves withdrawing the drug and steroids (depending on the degree of acute kidney injury and clinical assessment).
In the cases presented, the deterioration in kidney func tion was temporally associated with treatment with PPIs, stopping PPIs led to an improvement in kidney function, and the biopsy findings were consistent with an allergic type acute tubulointerstitial nephritis. Although these findings are insufficient to show causation, due to possible confounding factors (such as the use of other drugs), our data combined with other case reports are highly sugges tive. In our renal unit, PPIs were the leading likely cause of biopsy proved acute interstitial nephritis, 13 which is a com mon cause of acute kidney injury. After PPIs were stopped, kidney function improved considerably, consistent with the case reports in the literature. The development of chronic kidney disease after acute kidney injury has long term det rimental effects on health, including increased cardiovas cular disease. Delays in making the diagnosis are important because this may affect prognosis.
The incidence of acute interstitial nephritis related to PPIs remains uncertain, but it is thought to be relatively uncommon. During a 22 month period, we identified six cases of acute interstitial nephritis associated with PPIs, proved by biopsy, in a renal centre serving a population of 1.1 million people. 13 An earlier study in the United Kingdom reported eight cases in a four year period. 7 Analysis of the F  134  81  62  158  28  116  40  11  2  60  F  800  58  >90  196  23  106  46  16  3  81  F  10  96  49  294  13  95  49  8  4  61  M  540  82  84  123  52  102  65  12 †  5  87  F  278  83  58  172  25  135  33  9 eGFR=estimated glomerular filtration rate, calculated by the modification of diet in renal disease formula (ml/min/1.73 m 2 ). *1-12 months. †No steroids.
PRACTICE
Medicines and Healthcare products Regulatory Agency reporting scheme in the UK (www.mhra.gov.uk/Onlineserv ices/Medicines/Druganalysisprints/index.htm) found 74 cases of acute interstitial nephritis related to PPIs between 1992 and December 2009. The condition is likely to be con siderably underreported because of a lack of awareness of the condition, the nonspecific nature of the symptoms, and attributing decline in kidney function to other conditions.
Although the incidence of acute kidney injury induced by proton pump inhibitors is likely to be low (even account ing for underreporting), it is important to consider it in the differential diagnosis of kidney disease. Acute interstitial nephritis induced by PPIs is an iatrogenic cause of kid ney injury that can be wholly or partially reversed in most patients, avoiding the development of chronic kidney dis ease and its deleterious sequelae.
The relative infrequency of kidney function testing and the nonspecific symptoms of this condition suggest that a high index of suspicion is needed. If a decline in renal function is noted, PPIs should be considered as a cause and stopped. They can often be replaced with lifestyle measures, antacids, and ranitidine (which is very rarely associated with acute interstitial nephritis 14 ). PPIs are not without risks and should always be appropriately prescribed.
